Estadístiques de Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non-small cell lung carcinoma: the ROSING study
Visites totals
| views | |
|---|---|
| Assessment of a new ROS1 immunohistochemistry clone (SP384) for the identification of ROS1 rearrangements in patients with non-small cell lung carcinoma: the ROSING study | 95 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 2 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| conde-jto-asse.pdf(legacy) | 130 |
| conde-jto-asse.pdf | 55 |
Vistes principals per país
| views | |
|---|---|
| United States | 48 |
| Spain | 12 |
| Belgium | 8 |
| Germany | 7 |
| Sweden | 5 |
| China | 3 |
| France | 2 |
| Ireland | 2 |
| Canada | 1 |
| Czechia | 1 |
| India | 1 |
| Iran | 1 |
| Japan | 1 |
| Macedonia | 1 |
| Taiwan | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 10 |
| Madrid | 8 |
| Mountain View | 8 |
| Ashburn | 5 |
| Cambridge | 4 |
| Menlo Park | 3 |
| Shenzhen | 3 |
| Ann Arbor | 2 |
| Boardman | 2 |
| Cupertino | 2 |
| Durham | 2 |
| Fairfield | 2 |
| Barcelona | 1 |
| Bitola | 1 |
| Dearborn | 1 |
| Dublin | 1 |
| Garching | 1 |
| Indianapolis | 1 |
| Rochester | 1 |
| San Diego | 1 |
| Seattle | 1 |
| Toronto | 1 |
| Uwajima | 1 |
| Villena | 1 |